First Manhattan CO Solid Biosciences Inc. Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.74 - $1.79 $296 - $716	400 Added 20.0%	2,400 $2,000
Q1 2020 May 06, 2020	BUY	$2.31 - $4.43 $4,620 - $8,860	2,000 New	2,000 $4,000
Q4 2019 Feb 13, 2020	SELL	$2.82 - $12.9 $5,640 - $25,800	-2,000 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$21.32 - $46.34 $21,320 - $46,340	1,000 Added 100.0%	2,000 $53,000
Q1 2018 Apr 20, 2018	BUY	$7.19 - $33.17 $7,190 - $33,170	1,000 New	1,000 $7,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.